Detection rate of FDG-PET/CT for occult cancer in patients with cryptogenic ischemic stroke.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 40944722.
- Also identified by DOI 10.1007/s00259-025-07558-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cryptogenic stroke represents a third of ischemic strokes and has a significant recurrence rate. Occult cancer has been Identified as a causal factor in up to 5-10% of this type of strokes. We propose that a whole body FDG-PET/CT may increase the detection rate of occult cancer diagnosis in patients with cryptogenic stroke. Observational prospective study including patients with cryptogenic ischemic stroke who underwent an FDG-PET/CT scan. Clinical, radiological (three territory sign) and specific analytical measurements (D-dimer) were also informed. A total of 140 patients were included in the study, with a mean age of 71. The PET scan showed abnormalities in 30% of patients with cryptogenic stroke, with a confirmed cancer diagnosis in 18%. Elevated D-dimer levels and a higher OCCULT-5 score were associated with occult cancer. Occult cancer was found in 18% of cryptogenic stroke cases in our study, evidenced by whole body FDF-PET/CT scans, which results in significant therapeutic and prognostic implications. Some imaging and analytical determinations seem to have potential for the selection of eligible patients for more advanced examinations.
Medical subject headings
- Positron Emission Tomography Computed Tomography
- Ischemic Stroke
- Fluorodeoxyglucose F18